A Phase 3 Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- George F Tidmarsh, MD, PhD
La Jolla Pharmaceutical Company
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
115 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Canberra Hospital
Garran, Australian Capital Territory, Australia
- John Hunter Hospital
New Lambton Heights, New South Wales, Australia
- Nepean Hospital
Penrith, New South Wales, Australia
- Royal North Shore Hospital
St Leonards, New South Wales, Australia
- the Wesley Hospital
Auchenflower, Queensland, Australia
- Royal Brisbane & Women'S Hospital
Herston, Queensland, Australia
- Gold Coast University Hospital
Southport, Queensland, Australia
- Princess Alexandra Hospital
Woolloongabba, Queensland, Australia
- Flinders Medical Centre
Bedford Park, South Australia, Australia
- Royal Hobart Hospital
Hobart, Tasmania, Australia
- Monash Medical Centre
Clayton, Victoria, Australia
- Frankston Hospital
Frankston, Victoria, Australia
- Austin Hospital
Heidelberg, Victoria, Australia
- St. Vincent'S Hospital
Melbourne, Victoria, Australia
- Royal Melbourne Hospital
Parkville, Victoria, Australia
- Fiona Stanley Hospital
Murdoch, Western Australia, Australia
- Royal Perth Hospital
Perth, Western Australia, Australia
- Royal Adelaide Hospital
Adelaide, Australia
- Uz Antwerpen
Antwerp, Belgium
- Brugmann University Hospital
Brussels, Belgium
- Erasme University Hospital
Brussels, Belgium
- Uz Brussel
Brussels, Belgium
- Uz Gent
Ghent, Belgium
- South Health Campus & Rockyview General Hospital
Calgary, Alberta, Canada
- Royal Alexandra Hospital
Edmonton, Alberta, Canada
- University of Alberta Hospital
Edmonton, Alberta, Canada
- St. Paul'S Hospital
Vancouver, British Columbia, Canada
- Royal Jubilee Hospital
Victoria, British Columbia, Canada
- Victoria General Hospital
Victoria, British Columbia, Canada
- Kingston General Hospital
Kingston, Ontario, Canada
- the Ottawa Hospital - Civic Campus
Ottawa, Ontario, Canada
- the Ottawa Hospital - General Campus
Ottawa, Ontario, Canada
- St. Michael'S Hospital
Toronto, Ontario, Canada
- Helsinki University Central Hospital
Helsinki, Finland
- Kuopio University Hospital
Kuopio, Finland
- Tampere University Hospital
Tampere, Finland
- Turku University Hospital
Turku, Finland
- Jean Minjoz Hospital
Besançon, France
- Hospital Roger Salengro, Chru de Lille
Lille, France
- Chu Nice
Nice, France
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Mar 2015
- Primary completion
- 1 Dec 2016
- Completion
- 18 Feb 2017
- Last update posted
- 27 Mar 2018
- Registered enrollment
- 344
- Registry id
- NCT02338843
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 11 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.